TTX Share Price Performance
Recent TTX News & Updates
No updates
Tetratherix Limited Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.10
- Gross Margin
- -115.90%
- Net Profit Margin
- -678.07%
- Debt/Equity Ratio
- -211.4%
Tetratherix Limited Competitors
About TTX
- Founded
- 2015
- Employees
- n/a
- CEO
- WebsiteView website
Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company has used its Tetramatrix platform technology to manufacture and provide products in the areas of bone regeneration, tissue spacing, and tissue healing applications. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.
Australian Market Performance
- 7 Days: -0.2%
- 3 Months: 5.6%
- 1 Year: 8.6%
- Year to Date: 5.1%
In the last week, the market has been flat, with a notable exception in the Materials sector dropping 4.2%. Meanwhile, the market is actually up 8.6% over the past year. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading